chr12-26122193-A-G
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_030762.3(BHLHE41):āc.1322T>Cā(p.Leu441Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000842 in 1,444,256 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ). Synonymous variant affecting the same amino acid position (i.e. L441L) has been classified as Likely benign.
Frequency
Consequence
NM_030762.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BHLHE41 | NM_030762.3 | c.1322T>C | p.Leu441Pro | missense_variant | 5/5 | ENST00000242728.5 | |
SSPN | XM_011520853.4 | c.-31+41A>G | intron_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BHLHE41 | ENST00000242728.5 | c.1322T>C | p.Leu441Pro | missense_variant | 5/5 | 1 | NM_030762.3 | P1 | |
SSPN | ENST00000538142.5 | c.-31+41A>G | intron_variant | 4 | |||||
SSPN | ENST00000534829.5 | n.101+41A>G | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000578 AC: 87AN: 150512Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000368 AC: 25AN: 67910Hom.: 0 AF XY: 0.000312 AC XY: 12AN XY: 38430
GnomAD4 exome AF: 0.000873 AC: 1129AN: 1293744Hom.: 1 Cov.: 30 AF XY: 0.000858 AC XY: 545AN XY: 635550
GnomAD4 genome AF: 0.000578 AC: 87AN: 150512Hom.: 0 Cov.: 31 AF XY: 0.000463 AC XY: 34AN XY: 73460
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 05, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at